Prospective, randomized, controlled, double-blind, multi-center, multinational study on the safety and efficacy of 6% Hydroxyethyl starch (HES) sOlution versus an Electrolyte solutioN In patients undergoing eleCtive abdominal Surgery: study protocol for the PHOENICS study
Jazyk angličtina Země Anglie, Velká Británie Médium electronic
Typ dokumentu protokol klinické studie, časopisecké články
PubMed
35193648
PubMed Central
PMC8862305
DOI
10.1186/s13063-022-06058-6
PII: 10.1186/s13063-022-06058-6
Knihovny.cz E-zdroje
- Klíčová slova
- Blood loss, Colloids, Double-blinded, HES, Hydroxyethyl starch, Multi-center, Multinational, Non-inferiority trial, Randomized controlled trial, Safety, Surgery, Volume therapy,
- MeSH
- břicho * chirurgie MeSH
- deriváty hydroxyethylového škrobu * škodlivé účinky chemie MeSH
- dvojitá slepá metoda MeSH
- elektrolyty MeSH
- lidé MeSH
- multicentrické studie jako téma MeSH
- náhražky plazmy škodlivé účinky MeSH
- prospektivní studie MeSH
- randomizované kontrolované studie jako téma MeSH
- senioři nad 80 let MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- protokol klinické studie MeSH
- Názvy látek
- deriváty hydroxyethylového škrobu * MeSH
- elektrolyty MeSH
- náhražky plazmy MeSH
BACKGROUND: Hydroxyethyl starch (HES) solutions are used for volume therapy to treat hypovolemia due to acute blood loss and to maintain hemodynamic stability. This study was requested by the European Medicines Agency (EMA) to provide more evidence on the long-term safety and efficacy of HES solutions in the perioperative setting. METHODS: PHOENICS is a randomized, controlled, double-blind, multi-center, multinational phase IV (IIIb) study with two parallel groups to investigate non-inferiority regarding the safety of a 6% HES 130 solution (Volulyte 6%, Fresenius Kabi, Germany) compared with a crystalloid solution (Ionolyte, Fresenius Kabi, Germany) for infusion in patients with acute blood loss during elective abdominal surgery. A total of 2280 eligible patients (male and female patients willing to participate, with expected blood loss ≥ 500 ml, aged > 40 and ≤ 85 years, and ASA Physical status II-III) are randomly assigned to receive either HES or crystalloid solution for the treatment of hypovolemia due to surgery-induced acute blood loss in hospitals in up to 11 European countries. The dosing of investigational products (IP) is individualized to patients' volume needs and guided by a volume algorithm. Patients are treated with IP for maximally 24 h or until the maximum daily dose of 30 ml/kg body weight is reached. The primary endpoint is the treatment group mean difference in the change from the pre-operative baseline value in cystatin-C-based estimated glomerular filtration rate (eGFR), to the eGFR value calculated from the highest cystatin-C level measured during post-operative days 1-3. Further safety and efficacy parameters include, e.g., combined mortality/major post-operative complications until day 90, renal function, coagulation, inflammation, hemodynamic variables, hospital length of stay, major post-operative complications, and 28-day, 90-day, and 1-year mortality. DISCUSSION: The study will provide important information on the long-term safety and efficacy of HES 130/0.4 when administered according to the approved European product information. The results will be relevant for volume therapy of surgical patients. TRIAL REGISTRATION: EudraCT 2016-002162-30 . ClinicalTrials.gov NCT03278548.
Department of Anaesthesiology and Intensive Therapy 5th Military Clinical Hosptial Krakow Poland
Department of Anesthesia Reanimation and Pain Therapy Clinic University Hospital Valencia Spain
Department of Anesthesiology and Intensive Care Medicine Medical University of Graz Graz Austria
Department of Anesthesiology and Intensive Medicine University Hospital Motol Prague Czech Republic
Department of Anesthesiology University Medical Center Groningen Groningen The Netherlands
Department of Outcomes Research Anesthesiology Institute Cleveland Clinic Cleveland OH USA
Department of Surgery Clinic University Hospital Valencia Spain
European Society of Anaesthesiology and Intensive Care Brussels Belgium
Fresenius Kabi Deutschland GmbH Bad Homburg Germany
Institute of Anesthesiology University and University Hospital of Zürich Zürich Switzerland
Service d'Anesthésie Réanimation Hôpital Européen Georges Pompidou Paris France
Zobrazit více v PubMed
Gutierrez G, Reines HD, Wulf-Gutierrez ME. Clinical review: hemorrhagic shock. Critical Care. 2004;8(5):373–381. doi: 10.1186/cc2851. PubMed DOI PMC
Chappell D, Westphal M, Jacob M. The impact of the glycocalyx on microcirculatory oxygen distribution in critical illness. Current Opinion in Anaesthesiology. 2009;22(2):155–162. doi: 10.1097/ACO.0b013e328328d1b6. PubMed DOI
Chappell D, Jacob M. Flüssigkeits- und Volumentherapie 2013 Fluid and volume therapy in 2013. Notfall + Rettungsmedizin. 2013;16:617–624. doi: 10.1007/s10049-013-1805-8. DOI
Heringlake M, Heinze H, Brauer K. Perioperatives Flüssigkeitsmanagement - Welches Volumen für welchen Patienten? Anasthesiologie Intensivmedizin Notfallmedizin Schmerztherapie. 2012;47(07/08):482–489. doi: 10.1055/s-0032-1323570. PubMed DOI
Yates DRA, Davies SJ, Milner HE, Wilson RJT. Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery. British Journal of Anaesthesia. 2014;112(2):281–289. doi: 10.1093/bja/aet307. PubMed DOI
Martin C, Jacob M, Vicaut E, Guidet B, Van Aken H, Kurz A. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology. 2013;118:387–394. doi: 10.1097/ALN.0b013e31827e5569. PubMed DOI
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Critical Care Medicine. 2011;39(2):259–265. doi: 10.1097/CCM.0b013e3181feeb15. PubMed DOI
Sadaka F, Juarez M, Naydenov S, O’Brien J. Fluid resuscitation in septic shock: the effect of increasing fluid balance on mortality. J Intens Care Med. 2014;29(4):213–217. doi: 10.1177/0885066613478899. PubMed DOI
Payen D, de Pont AC, Sakr Y, Spies C, Reinhart K, Vincent JL. A positive fluid balance is associated with a worse outcome in patients with acute renal failure. Crit Care. 2008;12(3):R74. doi: 10.1186/cc6916. PubMed DOI PMC
Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL, Program to Improve Care in Acute Renal Disease (PICARD) Study Group Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney International. 2009;76(4):422–427. doi: 10.1038/ki.2009.159. PubMed DOI
Van Der Linden P, James M, Mythen M, Weiskopf RB. Safety of modern starches used during surgery. Anesthesia and Analgesia. 2013;116(1):35–48. doi: 10.1213/ANE.0b013e31827175da. PubMed DOI
Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, Madsen KR, Møller MH, Elkjær JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Søe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjældgaard AL, Fabritius ML, Mondrup F, Pott FC, Møller TP, Winkel P, Wetterslev J, 6S Trial Group. Scandinavian Critical Care Trials Group Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. New England Journal of Medicine. 2012;367(2):124–134. doi: 10.1056/NEJMoa1204242. PubMed DOI
Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, Glass P, Lipman J, Liu B, McArthur C, McGuinness S, Rajbhandari D, Taylor CB, Webb SAR. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. New England Journal of Medicine. 2012;367(20):1901–1911. doi: 10.1056/NEJMoa1209759. PubMed DOI
Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. New England Journal of Medicine. 2008;358(2):125–139. doi: 10.1056/NEJMoa070716. PubMed DOI
Futier E, Garot M, Godet T, Biais M, Verzilli D, Ouattara A, Huet O, Lescot T, Lebuffe G, Dewitte A, Cadic A, Restoux A, Asehnoune K, Paugam-Burtz C, Cuvillon P, Faucher M, Vaisse C, el Amine Y, Beloeil H, Leone M, Noll E, Piriou V, Lasocki S, Bazin JE, Pereira B, Jaber S, for the FLASH Trial Group Effect of hydroxyethyl starch vs saline for volume replacement therapy on death or postoperative complications among high-risk patients undergoing major abdominal surgery: the FLASH Randomized Clinical Trial. JAMA. 2020;323(3):1346–1357. doi: 10.1001/jama.2019.20833. PubMed DOI PMC
Kabon B, Sessler DI, Kurz A, Maheshwari K, Babazade R, Fiffick A, et al. Effect of intraoperative goal-directed balanced crystalloid versus colloid administration on major postoperative morbidity: a randomized trial. Anesthesiology. 2019;130(5):728–744. doi: 10.1097/ALN.0000000000002601. PubMed DOI
Joosten A, Delaporte A, Ickx B, Touihri K, Stany I, Barvais L, van Obbergh L, Loi P, Rinehart J, Cannesson M, van der Linden P. Crystalloid versus colloid for intraoperative goal-directed fluid therapy using a closed-loop system: a randomized, double-blinded, controlled trial in major abdominal surgery. Anesthesiology. 2018;128(1):55–66. doi: 10.1097/ALN.0000000000001936. PubMed DOI
Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. Journal of the American College of Surgeons. 2006;203(6):865–877. doi: 10.1016/j.jamcollsurg.2006.08.026. PubMed DOI
Story DA, Leslie K, Myles PS, Fink M, Poustie SJ, Forbes A, Yap S, Beavis V, Kerridge R, on behalf of the REASON Investigators, Australian and New Zealand College of Anaesthetists Trials Group Complications and mortality in older surgical patients in Australia and New Zealand (the REASON study): a multicentre, prospective, observational study. Anaesthesia. 2010;65(10):1022–1030. doi: 10.1111/j.1365-2044.2010.06478.x. PubMed DOI
Kozek-Langenecker SA, Ahmed AB, Afshari A, Albaladejo P, Aldecoa C, Barauskas G, de Robertis E, Faraoni D, Filipescu DC, Fries D, Haas T, Jacob M, Lancé MD, Pitarch JVL, Mallett S, Meier J, Molnar ZL, Rahe-Meyer N, Samama CM, Stensballe J, van der Linden PJF, Wikkelsø AJ, Wouters P, Wyffels P, Zacharowski K. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesthesiol. 2017;34(6):270–382. doi: 10.1097/EJA.0000000000000630. PubMed DOI
Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, van Lente F, Zhang YL, Coresh J, Levey AS, CKD-EPI Investigators Estimating glomerular filtration rate from serum creatinine and cystatin C. New England Journal of Medicine. 2012;367(1):20–29. doi: 10.1056/NEJMoa1114248. PubMed DOI PMC
Felicio ML, de Andrade RR, Castiglia YMM, Silva MA de M, Vianna PTG, Martins AS. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass. Brazilian J Cardiovasc Surg. 2009;24(3):305–311. doi: 10.1590/S0102-76382009000400008. PubMed DOI
European Medicines Agency. ICH Topic E 9 Statistical Principles for Clinical Trials. London; 1998.
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care. 2004;8(4):R204–R212. doi: 10.1186/cc2872. PubMed DOI PMC
De Hert S, De Baerdemaeker L. Why hydroxyethyl starch solutions should not be banned from the operating room. Anaesthesiology Intensive Therapy. 2014;46(5):336–341. doi: 10.5603/AIT.2014.0057. PubMed DOI
Marx G, Schindler AW, Mosch C, Albers J, Bauer M, Gnass I, Hobohm C, Janssens U, Kluge S, Kranke P, Maurer T, Merz W, Neugebauer E, Quintel M, Senninger N, Trampisch HJ, Waydhas C, Wildenauer R, Zacharowski K, Eikermann M. Intravascular volume therapy in adults. European Journal of Anaesthesiology. 2016;33(7):488–521. doi: 10.1097/EJA.0000000000000447. PubMed DOI PMC
Pearse RM, Harrison DA, MacDonald N, Gillies MA, Blunt M, Ackland G, Grocott MP, Ahern A, Griggs K, Scott R, Hinds C, Rowan K, OPTIMISE Study Group Effect of a perioperative, cardiac output-guided hemodynamic therapy algorithm on outcomes following major gastrointestinal surgery a randomized clinical trial and systematic review. JAMA. 2014;311(21):2181–2190. doi: 10.1001/jama.2014.5305. PubMed DOI
Van Kuijk JP, Flu WJ, Chonchol M, Hoeks SE, Winkel TA, Verhagen HJM, et al. Temporary perioperative decline of renal function is an independent predictor for chronic kidney disease. Clin J Am Soc Nephrol. 2010;5(7):1198–1204. doi: 10.2215/CJN.00020110. PubMed DOI PMC
Welten GM, Schouten O, Chonchol M. Temporary worsening of renal function after aortic surgery is associated with higher long-term mortality. J Vasc Surg. 2008;47(2):219–228. doi: 10.1016/j.jvs.2007.12.016. PubMed DOI
Boyd O, Jackson N. Clinical review: how is risk defined in high-risk surgical patient management? Crit Care. 2005;9(4):390–396. doi: 10.1186/cc3057. PubMed DOI PMC
Hamilton MA, Cecconi M, Rhodes A. A systematic review and meta-analysis on the use of preemptive hemodynamic intervention to improve postoperative outcomes in moderate and high-risk surgical patients. Anesthesia and Analgesia. 2011;112(6):1392–1402. doi: 10.1213/ANE.0b013e3181eeaae5. PubMed DOI
Khuri SF, Henderson WG, DePalma RG, Mosca C, Healey NA, Kumbhani DJ. Determinants of long-term survival after major surgery and the adverse effect of postoperative complications. Ann Surg. 2005;242(3):326–341. doi: 10.1097/01.sla.0000179621.33268.83. PubMed DOI PMC
Head J, Ferrie JE, Alexanderson K, Westerlund H, Vahtera J, Kivimäki M. Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study. BMJ. 2008;337(oct02 2):a1469. doi: 10.1136/bmj.a1469. PubMed DOI PMC
Calvert S, Shaw A. Perioperative acute kidney injury. Perioperative Medicine. 2012;1(1):6. doi: 10.1186/2047-0525-1-6. PubMed DOI PMC
Kheterpal S, Tremper KK, Englesbe MJ, O’Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD. Predictors of postoperative acute renal failure after noncardiac surgery in patients with previously normal renal function. Anesthesiology. 2007;107(6):892–902. doi: 10.1097/01.anes.0000290588.29668.38. PubMed DOI
Silva JM, De Oliveira AMRR, Nogueira FAM, Vianna PMM, Pereira Filho MC, Dias LF, et al. The effect of excess fluid balance on the mortality rate of surgical patients: a multicenter prospective study. Crit Care. 2013;17(6):R288. doi: 10.1186/cc13151. PubMed DOI PMC
Pearse RM, Harrison DA, James P, Watson D, Hinds C, Rhodes A, Grounds RM, Bennett ED. Identification and characterisation of the high-risk surgical population in the United Kingdom. Critical Care. 2006;10(3):R81. doi: 10.1186/cc4928. PubMed DOI PMC
Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A, European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology Mortality after surgery in Europe: a 7 day cohort study. The Lancet. 2012;380(9847):1059–1065. doi: 10.1016/S0140-6736(12)61148-9. PubMed DOI PMC
O’Connor ME, Kirwan CJ, Pearse RM, Prowle JR. Incidence and associations of acute kidney injury after major abdominal surgery. Intensive Care Medicine. 2016;42(4):521–530. doi: 10.1007/s00134-015-4157-7. PubMed DOI
Sear JW. Kidney dysfunction in the postoperative period. British Journal of Anaesthesia. 2005;95(1):20–32. doi: 10.1093/bja/aei018. PubMed DOI
ClinicalTrials.gov
NCT03278548